Hydroxychloroquine plus azithromycin early treatment of mild COVID-19 in an outpatient setting: a randomized, double-blinded, placebo-controlled clinical trial evaluating viral clearance
Cristhieni Rodrigues, Rodrigo S. Freitas-Santos, José Eduardo Levi, Andreza Almeida Senerchia, Ana Tarina Alvarez Lopes, Sergio Romero dos Santos, Rinaldo Focaccia Siciliano, Lı́gia Camera Pierrotti
Topics & Concepts
HydroxychloroquineMedicinePlaceboAzithromycinClinical endpointInternal medicineViral loadRandomized controlled trialClinical trialAdverse effectImmunologyCoronavirus disease 2019 (COVID-19)Human immunodeficiency virus (HIV)PathologyAntibioticsMicrobiologyBiologyDiseaseAlternative medicineInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research